Evgen Pharma Share Price | |
---|---|
Price | 3.85 |
Bid | 3.70 |
Ask | 4.00 |
Change | 0.00 (0.00%) |
Volume | 33,176 |
Open | 3.85 |
High | 3.85 |
Low | 3.85 |
Prev. Close | 3.85 |
Currency | GBX |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 275m |
Market Capitalisation | £11m |
Market Size | 30,000 |
52 Week High | 9.30 |
52 Week High Date | 10-Jun-2021 |
52 Week Low | 3.075 |
52 Week Low Date | 24-Mar-2022 |
# Trades | 1 |
---|---|
Vol. Sold | 33,176 |
Sold Value | £1,264.67 |
Vol. Bought | 0 |
Bought Value | £0.00 |
PE Ratio | -2.115 |
Earnings | -1.82 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
27-May-22 | 09:44:01 | 3.812 | 33,176 | Sell* | 3.70 | 4.00 | 1,265 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
31-Mar-21 | 31-Mar-21 | Notification of Holding | Susan (Sue) Foden held the position of Non-Executive Director at the time of this trade. Susan (Sue) Foden | 0.00 | 0 | 125,000 | |
31-Mar-21 | 31-Mar-21 | Notification of Holding | Huw Jones held the position of CEO at the time of this trade. Huw Jones | 0.00 | 0 | 62,500 | |
31-Mar-21 | 31-Mar-21 | Notification of Holding | Barry Clare held the position of Non-Executive Chairman at the time of this trade. Barry Clare | 0.00 | 0 | 1,023,441 | |
05-Mar-21 | 03-Mar-21 | Placing | Richard Moulson held the position of CFO at the time of this trade. Richard Moulson | 8.00 | GBX | 3,787 | 45,454 |
19-Jan-16 | 18-Jan-16 | Buy | John Bradshaw held the position of CFO at the time of this trade. John Bradshaw | 22.25 | GBX | 40,000 | 40,000 |
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions and the lead product is SFX-01.